Promega
Exhibition Partner
Promega is dedicated to advancing technologies and compound profiling services that address the unique challenges of Covalent Drug Discovery. From measuring real-time target engagement and residence time in live cells, to evaluating selectivity across target class families, to assessing cellular responses and safety liabilities. Our NanoBRET™ Target Engagement platform enables measurement of covalent binding, while our Selectivity Profiling Services provide physiologically relevant insight into offtarget activity. Tailored R&D Solutions deliver customized assays for time-dependent inhibition, mutant target testing, and more—helping researchers design covalent inhibitors with confidence.
